Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Number of holders
-
498
-
Total 13F shares, excl. options
-
25,148,571
-
Shares change
-
+5,458,047
-
Total reported value, excl. options
-
$2,232,467,554
-
Value change
-
+$479,464,342
-
Put/Call ratio
-
232%
-
Number of buys
-
368
-
Number of sells
-
-146
-
Price
-
$88.73
Significant Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q1 2021
610 filings reported holding ARKG - ARK ETF TR - GENOMIC REV ETF as of Q1 2021.
ARK ETF TR - GENOMIC REV ETF (ARKG) has 498 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25,148,571 shares
.
Largest 10 shareholders include MORGAN STANLEY (3,361,787 shares), BANK OF AMERICA CORP /DE/ (1,950,947 shares), UBS Group AG (1,552,154 shares), Sloy Dahl & Holst, LLC (1,359,168 shares), LPL Financial LLC (1,111,109 shares), WELLS FARGO & COMPANY/MN (1,011,709 shares), Eversept Partners, LP (806,932 shares), COMMONWEALTH EQUITY SERVICES, LLC (764,724 shares), ADVISOR GROUP HOLDINGS, INC. (575,319 shares), and ROYAL BANK OF CANADA (435,644 shares).
This table shows the top 498 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.